Literature DB >> 28964534

Preliminary results of the association of Palbociclib and radiotherapy in metastatic breast cancer patients.

Sophie Hans1, Paul Cottu1, Youlia M Kirova2.   

Abstract

Entities:  

Keywords:  Concurrent Palbociclib; Metastatic breast cancer; Radiotherapy

Mesh：

Substances：

Year:  2017        PMID： 28964534     DOI： 10.1016/j.radonc.2017.09.010

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN： 0167-8140            Impact factor:   6.280


× No keyword cloud information.
  13 in total

1.  CDK 4/6 inhibitors and stereotactic radiation in the management of hormone receptor positive breast cancer brain metastases.

Authors:  Nicholas B Figura; Thrisha K Potluri; Homan Mohammadi; Daniel E Oliver; John A Arrington; Timothy J Robinson; Arnold B Etame; Nam D Tran; James K Liu; Hatem Soliman; Peter A Forsyth; Solmaz Sahebjam; H Michael Yu; Hyo S Han; Kamran A Ahmed
Journal:  J Neurooncol       Date:  2019-08-09       Impact factor: 4.130

Review 2.  Safety and Tolerability of Metastasis-Directed Radiation Therapy in the Era of Evolving Systemic, Immune, and Targeted Therapies.

Authors:  Elizabeth Guimond; Chiaojung Jillian Tsai; Ali Hosni; Grainne O'Kane; Jonathan Yang; Aisling Barry
Journal:  Adv Radiat Oncol       Date:  2022-07-14

3.  Abemaciclib, a Selective CDK4/6 Inhibitor, Enhances the Radiosensitivity of Non-Small Cell Lung Cancer In Vitro and In Vivo.

Authors:  Sarwat Naz; Anastasia Sowers; Rajani Choudhuri; Maria Wissler; Janet Gamson; Askale Mathias; John A Cook; James B Mitchell
Journal:  Clin Cancer Res       Date:  2018-05-01       Impact factor: 12.531

4.  Enhanced dermatologic toxicity following concurrent treatment with palbociclib and radiation therapy: A case report.

Authors:  Jay A Messer; Ekim Ekinci; Tejal A Patel; Bin S Teh
Journal:  Rep Pract Oncol Radiother       Date:  2019-03-20

5.  Safety and Efficacy of Palbociclib and Radiation Therapy in Patients With Metastatic Breast Cancer: Initial Results of a Novel Combination.

Authors:  Mudit Chowdhary; Neilayan Sen; Akansha Chowdhary; Lydia Usha; Melody A Cobleigh; Dian Wang; Kirtesh R Patel; Parul N Barry; Ruta D Rao
Journal:  Adv Radiat Oncol       Date:  2019-04-03

Review 6.  Role of the Combination of Cyclin-Dependent Kinase Inhibitors (CDKI) and Radiotherapy (RT) in the Treatment of Metastatic Breast Cancer (MBC): Advantages and Risks in Clinical Practice.

Authors:  Ambrogio Gagliano; Angela Prestifilippo; Ornella Cantale; Gianluca Ferini; Giacomo Fisichella; Paolo Fontana; Dorotea Sciacca; Dario Giuffrida
Journal:  Front Oncol       Date:  2021-06-17       Impact factor: 6.244

7.  A single-center retrospective safety analysis of cyclin-dependent kinase 4/6 inhibitors concurrent with radiation therapy in metastatic breast cancer patients.

Authors:  Andrea Emanuele Guerini; Sara Pedretti; Emiliano Salah; Edda Lucia Simoncini; Marta Maddalo; Ludovica Pegurri; Rebecca Pedersini; Lucia Vassalli; Nadia Pasinetti; Gloria Peretto; Luca Triggiani; Gianluca Costantino; Vanessa Figlia; Filippo Alongi; Stefano Maria Magrini; Michela Buglione
Journal:  Sci Rep       Date:  2020-08-12       Impact factor: 4.379

Review 8.  CDK4/6 inhibitors: a novel strategy for tumor radiosensitization.

Authors:  Yilan Yang; Jurui Luo; Xingxing Chen; Zhaozhi Yang; Xin Mei; Jinli Ma; Zhen Zhang; Xiaomao Guo; Xiaoli Yu
Journal:  J Exp Clin Cancer Res       Date:  2020-09-15

9.  [Ribociclib in combination with endocrine therapy improves overall survival of pre-/perimenopausal breast cancer patients].

Authors:  David Krug; Alexander Fabian; Jürgen Dunst
Journal:  Strahlenther Onkol       Date:  2020-03       Impact factor: 3.621

Review 10.  The role of radiation therapy and systemic therapies in elderly with breast cancer.

Authors:  Valerio Nardone; Sara Falivene; Francesca Maria Giugliano; Marcella Gaetano; Pasqualina Giordano; Matteo Muto; Bruno Daniele; Cesare Guida
Journal:  Transl Cancer Res       Date:  2020-01       Impact factor: 1.241
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.